Abeona's (ABEO) Gene Therapy Launch Hits A Pivotal Reimbursement Milestone
On August 13, Abeona Therapeutics (NASDAQ:ABEO) reported second-quarter results that captured a company scaling a genuinely new kind of medicine while working through the bumps that come with it.



